skeletal muscle relaxant

19
SKELETAL MUSCLE RELAXANT S. Parasuraman, M.Pharm., Ph.D., Senior Lecturer, Faculty of Pharmacy, AIMST University

Upload: parasuraman-s

Post on 21-Jan-2018

369 views

Category:

Education


0 download

TRANSCRIPT

Page 1: Skeletal muscle relaxant

SKELETAL MUSCLE RELAXANT

S. Parasuraman, M.Pharm., Ph.D.,Senior Lecturer, Faculty of Pharmacy,

AIMST University

Page 2: Skeletal muscle relaxant

Skeletal muscle relaxant

• Skeletal muscle relaxants are drugs that act

peripherally at neuromuscular junction/ muscle fibre

itself or centrally in the cerebrospinal axis to reduce

muscle tone and/or cause paralysis.

• A muscle relaxants is a drug that affects skeletal

muscle function and decreases the muscle tone. It

may be used to improve symptoms such as muscle

spasms, pain, and hyperreflexia.

Page 3: Skeletal muscle relaxant

Peripherally acting muscle relaxants

Neuromuscular blocking agents

• Nondepolarizing (Competitive) blockers

– Long acting: d-Tubocurarine, Pancuronium, Doxacurium, Pipecuronium

– Intermediate acting: Vecuronium, Atracurium, Cisatracurium, Rocuronium, Rapacuronium

– Short acting: Mivacurium

• Depolarizing blockers: Succinylcholine (Sch), Decamethonium

Page 4: Skeletal muscle relaxant

Nondepolarizing (Competitive) blockers

• MOA: The site of action of both competitive anddepolarizing blockers is the end plate of skeletalmuscle fibres.

• Pharmacological actions:– Skeletal muscles: Intravenous injection of nondepolarizing

blockers rapidly produces muscle weakness followed byflaccid paralysis.

– Autonomic ganglia: produce some degree of ganglionicblockade

– Histamine release: d-TC releases histamine from mast cells.Histamine release contributes to the hypotension producedby d-TC. Flushing, bronchospasm and increased respiratorysecretions are other effects.

Page 5: Skeletal muscle relaxant

Nondepolarizing (Competitive) blockers

• Pharmacological actions (Cont.,):

– Cardiovascular system: d-Tubocurarine producessignificant fall in BP. This is due to

• ganglionic blockade

• histamine release and

• reduced venous return

– Gastrointestinal tract: The ganglion blocking activity ofcompetitive blockers may enhance postoperative paralyticileus after abdominal operations.

– Central nervous system: All neuromuscular blockers arequaternary compounds—do not cross blood-brain barrier.

Page 6: Skeletal muscle relaxant

Nondepolarizing blockers - Individual compounds

• d-Tubocurarine:

– Not clinical used do to its histaminic effects.

• Succinylcholine:

– SCh is the most commonly used muscle relaxant for passingtracheal tube. It induces rapid, complete and predictableparalysis with spontaneous recovery in ~5 min.

– Occasionally SCh is used by continuous i.v. infusion forproducing controlled muscle relaxation of longer duration.

– It should be avoided in younger children unless absolutelynecessary, because risk of hyperkalaemia and cardiacarrhythmia is higher.

Page 7: Skeletal muscle relaxant

• Pancuronium:

– It is a synthetic steroidal compound, ~5 times more potentand longer acting than d-TC.

– Because of longer duration of action, needing reversal, itsuse is now restricted to prolonged operations, especiallyneurosurgery.

• Pipecuronium:

– Muscle relaxant with a slow onset and long duration ofaction; steroidal in nature; recommended for prolongedsurgeries.

Nondepolarizing blockers - Individual compounds

Page 8: Skeletal muscle relaxant

• Vecuronium:

– It is a most commonly used muscle relaxant for routinesurgery and in intensive care units..

• Atracurium:

– Four times less potent than pancuronium and shorteracting.

• Rocuronium:

– Muscle relaxant with a rapid onset and intermediateduration of action which can be used as alternative to SChfor tracheal intubation without the disadvantages ofdepolarizing block and cardiovascular changes.

Nondepolarizing blockers - Individual compounds

Page 9: Skeletal muscle relaxant

Nondepolarizing blockers - Individual compoundsUses

• Adjuvants to general anaesthesia: The mostimportant use of neuromuscular blockers is asadjuvants to general anaesthesia. Choice of theneuromuscular blocker depends on the nature andduration of the procedure, pharmacokinetics of theblocker and cardiovascular stability that it provides.Vecuronium and rocuronium are the most frequentlyselected nondepolarizing blockers.

• Assisted ventilation: Critically ill patients in intensivecare units often need ventilatory support.

Page 10: Skeletal muscle relaxant

• Convulsions and trauma from electroconvulsivetherapy can be avoided by the use of musclerelaxants without decreasing the therapeutic benefit.

• Assisted ventilation: Critically ill patients in intensivecare units often need ventilatory support.

Nondepolarizing blockers - Individual compoundsUses

Page 11: Skeletal muscle relaxant

Directly acting muscle relaxants

• Dantrolene: Dantrolene acts on the RyR1 (Ryanodine

receptor) calcium channels in the sarcoplasmic

reticulum of skeletal muscles and prevents Ca2+

induced Ca2+ release through sarcoplasmic reticulum.

• Dantrolene is slowly but adequately absorbed from

the g.i.t. It penetrates brain and produces some

sedation, but has no selective effect on polysynaptic

reflexes responsible for spasticity.

Page 12: Skeletal muscle relaxant

Centrally acting muscle relaxants

Centrally acting Peripherally acting

Decrease muscle tone without reducing voluntary power

Cause muscle paralysis, voluntary movements lost

Selectively inhibit polysynaptic reflexes in CNS

Block neuromuscular transmission

Cause some CNS depression No effect on CNS

Given orally, sometimes parenterally

Practically always given i.v.

Used in chronic spastic conditions, acute muscle spasms, tetanus

Used for short-term purposes (surgical operations)

Comparative features of centrally and peripherally acting muscle relaxants

Page 13: Skeletal muscle relaxant

Centrally acting muscle relaxants

• Classification

Class Example

Mephenesin congeners MephenesinCarisoprodolChlorzoxazoneChlormezanoneMethocarbamol

Benzodiazepines Diazepam and others

GABA mimetic BaclofenThiocolchicoside

Central α2 agonist Tizanidine

Page 14: Skeletal muscle relaxant

Centrally acting muscle relaxants

Baclofen:

• This analogue of the inhibitory transmitter GABA actsas a selective GABAB receptor agonist.

• The primary site of action of baclofen is considered tobe in the spinal cord where it depresses bothpolysynaptic and monosynaptic reflexes.

• As such, it does produce muscle weakness, but is lesssedative than diazepam.

• Baclofen is well absorbed orally and is primarilyexcreted unchanged in urine with a t½ of 3–4 hours.

Page 15: Skeletal muscle relaxant

Centrally acting muscle relaxants

Baclofen:

• Side effects are drowsiness, mental confusion,weakness and ataxia; serum transaminases may rise.Sudden withdrawal after chronic use may causehallucinations, tachycardia and seizures.

Page 16: Skeletal muscle relaxant

Centrally acting muscle relaxants

Tizanidine:

• This clonidine congener is a central α2 adrenergic

agonist—inhibits release of excitatory amino acids in

the spinal interneurones. It may facilitate the

inhibitory transmitter glycine as well.

Page 17: Skeletal muscle relaxant

Centrally acting muscle relaxants

Tizanidine:

• Side effects are dry mouth, drowsiness, night-time

insomnia and hallucinations.

• Dose-dependent elevation of liver enzymes occurs.

Though no consistent effect on BP has been

observed, it should be avoided in patients receiving

antihypertensives, especially clonidine.

Page 18: Skeletal muscle relaxant

Uses of centrally acting muscle relaxants

• Acute muscle spasms

• Torticollis, lumbago, backache, neuralgias

• Anxiety and tension

• Spastic neurological diseases

• Tetanus

• Electroconvulsive therapy

• Orthopedic manipulations

Page 19: Skeletal muscle relaxant

References

• Tripathi KD. Essentials of Medical Pharmacology,7th Ed, New Delhi: Jaypee Brothers MedicalPublisher (P) Ltd, 2013.